These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 21832239)

  • 21. Potent antileukemic activity of curaxin CBL0137 against MLL-rearranged leukemia.
    Somers K; Kosciolek A; Bongers A; El-Ayoubi A; Karsa M; Mayoh C; Wadham C; Middlemiss S; Neznanov N; Kees UR; Lock RB; Gudkov A; Sutton R; Gurova K; Haber M; Norris MD; Henderson MJ
    Int J Cancer; 2020 Apr; 146(7):1902-1916. PubMed ID: 31325323
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Concurrent blockade of NF-κB and Akt pathways potentiates cisplatin's antitumor activity in vivo.
    Sun H; Zheng X; Wang Q; Yan J; Li D; Zhou Y; Lin Y; Zhang L; Wang X
    Anticancer Drugs; 2012 Nov; 23(10):1039-46. PubMed ID: 22760211
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effective inhibition of MYC-amplified group 3 medulloblastoma by FACT-targeted curaxin drug CBL0137.
    Wang J; Sui Y; Li Q; Zhao Y; Dong X; Yang J; Liang Z; Han Y; Tang Y; Ma J
    Cell Death Dis; 2020 Dec; 11(12):1029. PubMed ID: 33268769
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Concurrent blockade of the NF-kappaB and Akt pathways potently sensitizes cancer cells to chemotherapeutic-induced cytotoxicity.
    He HN; Wang X; Zheng XL; Sun H; Shi XW; Zhong YJ; Huang B; Yang L; Li JK; Liao LC; Zhang L; Hu LN; Lin Y
    Cancer Lett; 2010 Sep; 295(1):38-43. PubMed ID: 20207071
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curaxin-Induced DNA Topology Alterations Trigger the Distinct Binding Response of CTCF and FACT at the Single-Molecule Level.
    Lu K; Liu C; Liu Y; Luo A; Chen J; Lei Z; Kong J; Xiao X; Zhang S; Wang YZ; Ma L; Dou SX; Wang PY; Li M; Li G; Li W; Chen P
    Biochemistry; 2021 Feb; 60(7):494-499. PubMed ID: 33570402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of FACT in mammalian tissues suggests its role in maintaining of undifferentiated state of cells.
    Garcia H; Fleyshman D; Kolesnikova K; Safina A; Commane M; Paszkiewicz G; Omelian A; Morrison C; Gurova K
    Oncotarget; 2011 Oct; 2(10):783-96. PubMed ID: 21998152
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aaptamines from the marine sponge Aaptos sp. display anticancer activities in human cancer cell lines and modulate AP-1-, NF-κB-, and p53-dependent transcriptional activity in mouse JB6 Cl41 cells.
    Dyshlovoy SA; Fedorov SN; Shubina LK; Kuzmich AS; Bokemeyer C; Keller-von Amsberg G; Honecker F
    Biomed Res Int; 2014; 2014():469309. PubMed ID: 25215281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concordant and opposite roles of DNA-PK and the "facilitator of chromatin transcription" (FACT) in DNA repair, apoptosis and necrosis after cisplatin.
    Sand-Dejmek J; Adelmant G; Sobhian B; Calkins AS; Marto J; Iglehart DJ; Lazaro JB
    Mol Cancer; 2011 Jun; 10():74. PubMed ID: 21679440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin.
    Shi Y; Felley-Bosco E; Marti TM; Orlowski K; Pruschy M; Stahel RA
    BMC Cancer; 2012 Dec; 12():571. PubMed ID: 23211021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p53 induces NF-kappaB activation by an IkappaB kinase-independent mechanism involving phosphorylation of p65 by ribosomal S6 kinase 1.
    Bohuslav J; Chen LF; Kwon H; Mu Y; Greene WC
    J Biol Chem; 2004 Jun; 279(25):26115-25. PubMed ID: 15073170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LYG-202 augments tumor necrosis factor-α-induced apoptosis via attenuating casein kinase 2-dependent nuclear factor-κB pathway in HepG2 cells.
    Chen FH; Lu N; Zhang HW; Zhao L; He LC; Sun HP; You QD; Li ZY; Guo QL
    Mol Pharmacol; 2012 Nov; 82(5):958-71. PubMed ID: 22909797
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 9-Aminoacridine-based anticancer drugs target the PI3K/AKT/mTOR, NF-kappaB and p53 pathways.
    Guo C; Gasparian AV; Zhuang Z; Bosykh DA; Komar AA; Gudkov AV; Gurova KV
    Oncogene; 2009 Feb; 28(8):1151-61. PubMed ID: 19137016
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II.
    Espinoza JA; Kanellis DC; Saproo S; Leal K; Martinez JF; Bartek J; Lindström MS
    Nucleic Acids Res; 2024 May; 52(8):4151-4166. PubMed ID: 38340348
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nuclear factor-kappaB, induced in human carcinoma cell line A2780 by the new anthracycline men 10755, is devoid of transcriptional activity.
    Camarda G; Binaschi M; Maggi CA; Goso C
    Int J Cancer; 2002 Dec; 102(5):476-82. PubMed ID: 12432549
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A novel drug discovery strategy: mechanistic investigation of an enantiomeric antitumor agent targeting dual p53 and NF-κB pathways.
    Zhuang C; Sheng C; Shin WS; Wu Y; Li J; Yao J; Dong G; Zhang W; Sham YY; Miao Z; Zhang W
    Oncotarget; 2014 Nov; 5(21):10830-9. PubMed ID: 25350970
    [TBL] [Abstract][Full Text] [Related]  

  • 36. DNA-dependent protein kinase (DNA-PK)-dependent cisplatin-induced loss of nucleolar facilitator of chromatin transcription (FACT) and regulation of cisplatin sensitivity by DNA-PK and FACT.
    Dejmek J; Iglehart JD; Lazaro JB
    Mol Cancer Res; 2009 Apr; 7(4):581-91. PubMed ID: 19372586
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel NF-kappaB pathway involving IKKbeta and p65/RelA Ser-536 phosphorylation results in p53 Inhibition in the absence of NF-kappaB transcriptional activity.
    Jeong SJ; Pise-Masison CA; Radonovich MF; Park HU; Brady JN
    J Biol Chem; 2005 Mar; 280(11):10326-32. PubMed ID: 15611068
    [TBL] [Abstract][Full Text] [Related]  

  • 38. p53 serine 392 phosphorylation increases after UV through induction of the assembly of the CK2.hSPT16.SSRP1 complex.
    Keller DM; Lu H
    J Biol Chem; 2002 Dec; 277(51):50206-13. PubMed ID: 12393879
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of the NF-κB signaling pathway by the curcumin analog, 3,5-Bis(2-pyridinylmethylidene)-4-piperidone (EF31): anti-inflammatory and anti-cancer properties.
    Olivera A; Moore TW; Hu F; Brown AP; Sun A; Liotta DC; Snyder JP; Yoon Y; Shim H; Marcus AI; Miller AH; Pace TW
    Int Immunopharmacol; 2012 Feb; 12(2):368-77. PubMed ID: 22197802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The anti-cancer drugs curaxins target spatial genome organization.
    Kantidze OL; Luzhin AV; Nizovtseva EV; Safina A; Valieva ME; Golov AK; Velichko AK; Lyubitelev AV; Feofanov AV; Gurova KV; Studitsky VM; Razin SV
    Nat Commun; 2019 Mar; 10(1):1441. PubMed ID: 30926878
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.